The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells

We formerly demonstrated that vaccination with Wilms’ tumor 1 (WT1)-loaded autologous monocyte-derived dendritic cells (mo-DCs) can be a well-tolerated effective treatment in acute myeloid leukemia (AML) patients. Here, we investigated whether we could introduce the receptor for hyaluronic acid-medi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Willemen, Yannick, Van den Bergh, Johan M.J., Bonte, Sarah M., Anguille, Sébastien, Heirman, Carlo, Stein, Barbara M.H., Goossens, Herman, Kerre, Tessa, Thielemans, Kris, Peeters, Marc, Van Tendeloo, Viggo F.I., Smits, Evelien L.J., Berneman, Zwi N.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342027/
https://ncbi.nlm.nih.gov/pubmed/27659531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12170
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados